<code id='E08ADDE7F0'></code><style id='E08ADDE7F0'></style>
    • <acronym id='E08ADDE7F0'></acronym>
      <center id='E08ADDE7F0'><center id='E08ADDE7F0'><tfoot id='E08ADDE7F0'></tfoot></center><abbr id='E08ADDE7F0'><dir id='E08ADDE7F0'><tfoot id='E08ADDE7F0'></tfoot><noframes id='E08ADDE7F0'>

    • <optgroup id='E08ADDE7F0'><strike id='E08ADDE7F0'><sup id='E08ADDE7F0'></sup></strike><code id='E08ADDE7F0'></code></optgroup>
        1. <b id='E08ADDE7F0'><label id='E08ADDE7F0'><select id='E08ADDE7F0'><dt id='E08ADDE7F0'><span id='E08ADDE7F0'></span></dt></select></label></b><u id='E08ADDE7F0'></u>
          <i id='E08ADDE7F0'><strike id='E08ADDE7F0'><tt id='E08ADDE7F0'><pre id='E08ADDE7F0'></pre></tt></strike></i>

          focus

          focus

          author:entertainment    Page View:2882
          ADAM FEUERSTEIN/STAT

          You’re reading the web edition of ASCO in 30 Seconds, STAT’s guide to the American Society of Clinical Oncology annual meeting.  Sign up here.

          CHICAGO — It’s only Day 2, but the ASCO meeting is already in full force. That means hordes of oncologists filling the halls, reams of data streaming through the meeting, and incredibly long lines for even the worst food. And STAT reporters Angus Chen, Adam Feuerstein, and Matthew Herper are in the thick of it – on the heels of STAT’s own in-person event here, which was standing room only and came with its own share of thrills, chills, and not a little bit of audience laughter. More on that in a bit.

          advertisement

          Here’s a rundown of some of the big news from the first 24 hours of the meeting which, due to some weird kind of relativistic time dilation, represents about a week for our intrepid reporters.

          STAT+ Exclusive Story

          Already have an account? Log in

          STAT+

          This article is exclusive to STAT+ subscribers

          Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

          Already have an account? Log in

          Already have an account? Log in

          Monthly

          $39

          Totals $468 per year

          $39/month Get Started

          Totals $468 per year

          Starter

          $30

          for 3 months, then $39/month

          $30 for 3 months Get Started

          Then $39/month

          Annual

          $399

          Save 15%

          $399/year Get Started

          Save 15%

          11+ Users

          Custom

          Savings start at 25%!

          Request A Quote Request A Quote

          Savings start at 25%!

          2-10 Users

          $300

          Annually per user

          $300/year Get Started

          $300 Annually per user

          View All Plans

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          After affirmative action ruling, medical educators look to 'holistic review'
          After affirmative action ruling, medical educators look to 'holistic review'

          AnnaMoneymaker/GettyImagesAfterhavingadaytoreadthroughtheSupremeCourt’sdecisiononaffirmativeaction,s

          read more
          Biotech execs pursue obesity drug boom: ‘It’s the early innings’
          Biotech execs pursue obesity drug boom: ‘It’s the early innings’

          ElaineChenofSTAT,upperleft,talkedaboutobesitydrugswith,clockwise,RaymondStevenofStructureTherapeutic

          read more
          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more

          Lifetime voting ban for felony convictions struck down in Mississippi

          9:17InthisMarch10,2020,filephoto,votersworkontheirballotsinthekiosksinJackson,Miss.RogelioV.Solis/AP